Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Fresenius Medical Care North America's Renal Therapies Group is preparing its first shipment of multiBic dialysate solutions for use in continuous renal replacement therapy.
read more
Freyr has announced the launch of a web platform for Covid-19 driven with real-time information for manufacturers.
read more
Frontage Laboratories today announced that Carlos Orantes has been
appointed Chief Operating Officer. A twenty-year veteran of contract research and life science industries,
he will lead Frontage’s US operations, which comprise a 60,000 square foot...
read more
Fujifilm has announced the extension of its gene therapy and viral vaccine Fill/Finish capabilities to provide services in support of late phase candidates and commercial supply.
read more
FUJIFILM Diosynth Biotechnologies has announced an expansion to its United Kingdom location through the creation of a new BioCampus.
read more
FUJIFILM Diosynth Biotechnologies has commenced the planned capacity expansion of its Flexible Biomanufacturing Facility at its College Station, Texas location.
read more
Wednesday, August 27, 2014
FUJIFILM Diosynth Biotechnologies has announced continued expansion of its cell culture manufacturing capabilities with the addition of two 2000L single-use bioreactors. One each of these is being installed at the company's sites in Research Triangle...
read more
Monday, November 06, 2017
FUJIFILM is to invest a total of 3.2 billion yen on its CDMO sites in the U.S. and the U.K. in order to accelerate the expansion of the company's business for developing and manufacturing biopharmaceuticals under contract for other parties.
read more
Fujifilm Diosynth Biotechnologies has announced the reduction of cell line development timelines with its Apollo X™ Advanced Mammalian Expression System.
read more
Tuesday, November 22, 2022
FUJIFILM Corporation announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA. The new site will be operated by FUJIFILM Irvine Scientific,
read more
FUJIFILM Irvine Scientific announced plans to open a third manufacturing facility located in Tilburg, Netherlands.
read more
Thursday, September 30, 2021
FUJIFILM Irvine Scientific, Inc., announced that it completed construction and started the commissioning phase of its new manufacturing facility in Tilburg, the Netherlands. The commissioning milestone marks the beginning of validating the facility ...
read more
Wednesday, December 01, 2021
FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the establishment of an Innovation and ...
read more
Monday, December 14, 2020
FUJIFILM Irvine Scientific has announced the launch of Sterile Express Media Service (SEMS), for small-scale, rapid production of non-GMP media tested for sterility.
read more
Wednesday, December 08, 2021
FUJIFILM Irvine Scientific, Inc., announced that its new manufacturing facility in Tilburg, the Netherlands is now open and fully operational. The facility provides state-of-the-art Life Science manufacturing and joins locations in the U.S. and Japan...
read more